Back
CRISPR Therapeutics AG Stock Predictions

Pacaso, now reserving Nasdaq ticker PCSO, is offering shares at $2.80 until May 29.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.*Pacaso recently received their ticker reservation with Nasdaq
Sell
28
CRSP
CRISPR Therapeutics AG
Last Price:
$36.87
Seasonality Move:
7.25%
7 Day Trial
ALL ACCESS PASS
$
7

Could BOXABL Be the Tesla of Housing?
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.CRISPR Therapeutics AG Stock Forecast
-
Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 41.8% based on the past 8 years of stock performance.
-
CRISPR Therapeutics AG has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is CRISPR Therapeutics AG Stock Undervalued?The current CRISPR Therapeutics AG [CRSP] share price is $36.86. The Score for CRSP is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will CRISPR Therapeutics AG Stock Go Up Next Year?
-
Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 41.8% based on the past 8 years of stock performance.
CRISPR Therapeutics AG Stock Rating
Sell
28
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG overpriced?
-
CRISPR Therapeutics AG has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
CRISPR Therapeutics AG Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
crisprtx.com
52-Week Data
52-Week High:
67.88
52-Week Low:
30.04
Prediction Charts
Market Cap:
3.2B
Price in USD:
36.86
Volume:
1.3M
Beta:
2.03
Technical Analysis
SMA50:
37.49
SMA100:
40.05
SMA200:
43.86
52-Wk Change:
-33.86%
Stock Predictions
-
Is CRISPR Therapeutics AG stock public?Yes, CRISPR Therapeutics AG is a publicly traded company.
-
What is the CRISPR Therapeutics AG stock quote today?The CRISPR Therapeutics AG stock price is 36.86 USD today.
-
How to buy CRISPR Therapeutics AG stock online?You can buy CRISPR Therapeutics AG shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
May-6 | 36.92 | 33.16 | 36.97 | 33.03 |
May-7 | 34.51 | 34.25 | 34.64 | 33.50 |
May-8 | 34.88 | 36.14 | 36.86 | 34.12 |
May-9 | 36.39 | 35.62 | 37.34 | 35.55 |
May-12 | 36.54 | 37.59 | 38.02 | 36.26 |
May-13 | 37.74 | 37.22 | 37.90 | 36.29 |
May-14 | 37.21 | 35.60 | 38.64 | 35.38 |
May-15 | 35.32 | 36.31 | 36.36 | 34.87 |
May-16 | 37.30 | 38.77 | 38.98 | 36.71 |
May-19 | 38.19 | 38.68 | 39.00 | 37.70 |
May-20 | 38.81 | 39.25 | 40.27 | 37.74 |
May-21 | 38.80 | 36.99 | 39.41 | 36.88 |
May-22 | 37.00 | 37.53 | 37.89 | 36.80 |
May-23 | 36.47 | 36.86 | 37.20 | 36.36 |
CRISPR Therapeutics AG Earnings
CRISPR Therapeutics AG Earnings Report: Per Share CRISPR Therapeutics AG Earnings Q1 Q2 Q3 and Q4 last year and next year.
CRISPR Therapeutics AG Forecast Revenue Growth
CRISPR Therapeutics AG Stock Analysis: Historical quarterly revenues per share for CRISPR Therapeutics AG and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, an increase next quarter of $0.14 per share, a decrease this year of $0.31 per share, and an increase next year of $1.03 per share.
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.